13th Jul 2010 16:14
BTG plc: Results of 2010 Annual General Meeting
London, UK, 13 July 2010: BTG plc (LSE: BGC), the specialty pharmaceuticals company, announces that all resolutions were passed on a show of hands at its Annual General Meeting earlier today. The number of proxy votes lodged for each resolution prior to the meeting was as follows:
|
|
Total for* |
Total against |
Votes withheld |
|||
|
Resolution |
No. of votes |
% of vote |
No. of votes |
% of vote |
No. of votes |
|
|
1. |
Receive accounts together with reports of the Directors and Auditor |
186,528,596 |
99.86 |
256,219 |
0.14 |
1,021,402 |
|
2. |
Approve the remuneration report |
175,274,127 |
98.32 |
2,998,417 |
1.68 |
9,533,672 |
|
3. |
Re-elect Louise Makin |
186,517,625 |
99.88 |
230,527 |
0.12 |
1,058,065 |
|
4. |
Re-elect Peter Chambré |
186,536,429 |
99.88 |
225,023 |
0.12 |
1,044,765 |
|
5. |
Re-appoint Auditor |
184,864,584 |
98.98 |
1,910,898 |
1.02 |
1,030,734 |
|
6. |
Fix Auditor remuneration |
185,489,942 |
99.31 |
1,297,069 |
0.69 |
1,019,206 |
|
7. |
Political donations |
186,181,448 |
99.68 |
591,535 |
0.32 |
1,033,234 |
|
8. |
Authority to allot shares |
186,341,319 |
99.85 |
271,231 |
0.15 |
1,193,667 |
|
9. |
Disapplication of pre-emption rights |
186,688,337 |
99.96 |
69,420 |
0.04 |
1,048,460 |
|
10. |
Adopt new articles of association |
186,578,415 |
99.90 |
183,874 |
0.10 |
1,043,928 |
|
11. |
Call a general meeting on not less than 14 days' notice |
184,149,203 |
98.59 |
2,641,443 |
1.41 |
1,015,571 |
*Includes discretionary votes appointing the Chairman
For further information contact:
|
BTG |
Financial Dynamics |
|
Andy Burrows, Director of Investor Relations +44 (0)20 7575 1741; mobile: +44 (0)7990 530605 Rolf Soderstrom, Chief Financial Officer +44 (0)20 7575 0000 |
Ben Atwell +44 (0)20 7831 3113 |
About BTG
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products. For further information, visit: www.btgplc.com.
Related Shares:
BTG